Che Connon
Chief Executive Officer en BSF ENTERPRISE PLC .
Fortuna: 963 522 $ al 31/03/2024
Perfil
Che John Connon is the founder of Atelerix Ltd.
(founded in 2017) where he holds the title of Director.
He is also the founder of CellRev (founded in 2018) where he holds the title of Chief Technical Officer & Director.
Additionally, he is the founder of 3D Bio-Tissues Ltd.
(founded in 2019) where he holds the title of Chief Executive Officer & Director.
Currently, Dr. Connon is the Chief Executive Officer, MD & Director at BSF Enterprise Plc and a Professor-Tissue Engineering at Newcastle University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BSF ENTERPRISE PLC
12.51% | 30/09/2023 | 12 927 977 ( 12.51% ) | 963 522 $ | 31/03/2024 |
Cargos activos de Che Connon
Empresas | Cargo | Inicio |
---|---|---|
BSF ENTERPRISE PLC | Chief Executive Officer | - |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Founder | 05/06/2017 |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The private company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Founder | 01/01/2019 |
CellRev
CellRev Miscellaneous Commercial ServicesCommercial Services CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system. | Founder | 18/12/2018 |
Newcastle University | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BSF ENTERPRISE PLC | Finance |
Empresas privadas | 3 |
---|---|
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
CellRev
CellRev Miscellaneous Commercial ServicesCommercial Services CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system. | Commercial Services |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The private company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Health Technology |
- Bolsa de valores
- Insiders
- Che Connon